These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11473500)

  • 1. Selective serotonin reuptake inhibitors and violence: a review of the available evidence.
    Walsh MT; Dinan TG
    Acta Psychiatr Scand; 2001 Aug; 104(2):84-91. PubMed ID: 11473500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressants and suicidal behaviour in unipolar depression.
    Yerevanian BI; Koek RJ; Feusner JD; Hwang S; Mintz J
    Acta Psychiatr Scand; 2004 Dec; 110(6):452-8. PubMed ID: 15521830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
    Hall WD; Lucke J
    Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of selective serotonin reuptake inhibitors in children and adolescents.
    Wong IC; Besag FM; Santosh PJ; Murray ML
    Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
    Tandt H; Audenaert K; van Heeringen C
    Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.
    Fergusson D; Doucette S; Glass KC; Shapiro S; Healy D; Hebert P; Hutton B
    BMJ; 2005 Feb; 330(7488):396. PubMed ID: 15718539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACNP Task Force report on SSRIs and suicidal behavior in youth.
    Mann JJ; Emslie G; Baldessarini RJ; Beardslee W; Fawcett JA; Goodwin FK; Leon AC; Meltzer HY; Ryan ND; Shaffer D; Wagner KD
    Neuropsychopharmacology; 2006 Mar; 31(3):473-92. PubMed ID: 16319919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic potential of selective reuptake inhibitors in suicidal patients.
    Banki CM
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():61-5. PubMed ID: 7542677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases.
    Dubrall D; Fekete S; Leitzen S; Paschke LM; Romanos M; Schmid M; Gerlach M; Sachs B
    BMC Pharmacol Toxicol; 2023 Mar; 24(1):22. PubMed ID: 37004083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.
    Mourilhe P; Stokes PE
    Drug Saf; 1998 Jan; 18(1):57-82. PubMed ID: 9466088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
    Healy D
    Psychother Psychosom; 2003; 72(2):71-9. PubMed ID: 12601224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
    Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
    Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants and suicidal behaviour in the Psychiatric Emergency Clinic - preliminary report.
    Pregelj P; Ziherl S
    Psychiatr Danub; 2008 Jun; 20(2):224-6. PubMed ID: 18587294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.